Objective: To test whether transdermal holmone therapy can be safely administered to postmenopausal women with chronic viral hepatitis B and/or C. Design: Eighty-one postmenopausal women with chronic viral hepatitis B and/or C and with severe vasomotor symptoms were treated for 5 years with transdermal estradiol (50 mu g/day) continuously and with transdennal norethisterone (250 mu g/day) for 14 days of every 28-day cycle. Another 95 women with viral chronic hepatitis but without climacteric symptoms were used as controls. Liver enzymes (glutamic-oxalacetic transaminase, glutamic-pyruvic transarninase, gamma-glutamine-transferase, and alkaline phosphatase) were measured every year. Results: At baseline, liver enzymes were similar in the two groups, with the exception of gamma-GT, which was slightly higher in untreated women (P < 0.01). Liver enzymes did not significantly vary with time in hormone-treated and untreated women. No significant difference was observed between the two groups. Conclusions: Transdermal estradiol and norethisterone can be safely administered for a prolonged period to postmenopausal women with chronic viral B and/or C hepatitis.

Neutral effect of prolonged transdermal hormone therapy on liver function of postmenopausal women with chronic active hepatitis / Rinaldi, M; Cagnacci, Angelo; Pansini, Fe; de Aloysio, D; Sgarabotto, Mp; Bacchi Modena, A.. - In: MENOPAUSE. - ISSN 1072-3714. - STAMPA. - 12:5(2005), pp. 619-622. [10.1097/01.gme.0000172271.78314.6d]

Neutral effect of prolonged transdermal hormone therapy on liver function of postmenopausal women with chronic active hepatitis

CAGNACCI, Angelo;
2005

Abstract

Objective: To test whether transdermal holmone therapy can be safely administered to postmenopausal women with chronic viral hepatitis B and/or C. Design: Eighty-one postmenopausal women with chronic viral hepatitis B and/or C and with severe vasomotor symptoms were treated for 5 years with transdermal estradiol (50 mu g/day) continuously and with transdennal norethisterone (250 mu g/day) for 14 days of every 28-day cycle. Another 95 women with viral chronic hepatitis but without climacteric symptoms were used as controls. Liver enzymes (glutamic-oxalacetic transaminase, glutamic-pyruvic transarninase, gamma-glutamine-transferase, and alkaline phosphatase) were measured every year. Results: At baseline, liver enzymes were similar in the two groups, with the exception of gamma-GT, which was slightly higher in untreated women (P < 0.01). Liver enzymes did not significantly vary with time in hormone-treated and untreated women. No significant difference was observed between the two groups. Conclusions: Transdermal estradiol and norethisterone can be safely administered for a prolonged period to postmenopausal women with chronic viral B and/or C hepatitis.
2005
12
5
619
622
Neutral effect of prolonged transdermal hormone therapy on liver function of postmenopausal women with chronic active hepatitis / Rinaldi, M; Cagnacci, Angelo; Pansini, Fe; de Aloysio, D; Sgarabotto, Mp; Bacchi Modena, A.. - In: MENOPAUSE. - ISSN 1072-3714. - STAMPA. - 12:5(2005), pp. 619-622. [10.1097/01.gme.0000172271.78314.6d]
Rinaldi, M; Cagnacci, Angelo; Pansini, Fe; de Aloysio, D; Sgarabotto, Mp; Bacchi Modena, A.
File in questo prodotto:
File Dimensione Formato  
menopepatiti.pdf

Accesso riservato

Tipologia: Abstract
Dimensione 73.27 kB
Formato Adobe PDF
73.27 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/306199
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 5
social impact